Can one cell-line meet the demands of product quantities and varieties?

There is an industry need for new high performance technologies that achieve the goal of meeting the unmet needs of bio-manufacturing. These technologies must be: effective, safe, have decent capacity, rapid response, be cost-effective and simple to manufacture. Fraunhofer USA are attempting to produce these technologies. Pilot production has operated to USFDA cGMP standards. Should the technologies be biological- can …

#Bayer explore if plant #cell-lines can grow into the #vaccine industry leaders?

Bayer are exploring the possibility of plant cell lines as a dominant player in vaccine production.  Dr John Butler-Ransohoff the Project Manager for Plant-made Pharmaceuticals at Bayer Innovations is going to evaluate the current position of development and look at where the limiting factors and commercial opportunities lie; Why plant cell-lines are ideal for vaccine production and can address the …